Mark J. Murray
Director/Miembro de la Junta en Genevant Sciences Corp. .
Perfil
Mark J.
Murray was the founder of Protiva Biotherapeutics, Inc. founded in 2000, where he held the title of President & Chief Executive Officer from 2000 to 2008.
Currently, he is a Director at Genevant Sciences Corp.
Dr. Murray's former position was at Arbutus Biopharma Corp.
where he held the title of President, Chief Executive Officer & Director from 2011 to 2019.
Dr. Murray received a doctorate degree from Oregon Health & Science University.
Cargos activos de Mark J. Murray
| Empresas | Cargo | Inicio |
|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Mark J. Murray.
| Empresas | Cargo | Fin |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Director Ejecutivo | 24/06/2019 |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Director Ejecutivo | 02/12/2008 |
Formación de Mark J. Murray.
| Oregon Health & Science University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
- Bolsa de valores
- Insiders
- Mark J. Murray